Audio Clinical Professionals

Management of Medically Refractory Epilepsy

This session reviews Management of Medically Refractory Epilepsy and its most clinically relevant points for exam preparation and bedside decision-making.

This resource is private and requires a subscriber login to stream. SIGN IN to continue.

Duration

00:02:15

File size

1.32 MB

Practitioner-Guided Note

For Management of Medically Refractory Epilepsy, prioritize Medically refractory definition: failed ≥2 appropriate AEDs; <5% chance 3rd medication achieves control, Ketogenic diet: highly successful for Lennox-Gastaut, induces ketosis/mild acidosis, and Cannabidiol (CBD): FDA-approved for Lennox-Gastaut and Dravet syndromes when choosing therapy, counseling about risk, planning monitoring, and deciding when closer follow-up or escalation is needed.

Key Takeaways

Medically refractory definition: failed ≥2 appropriate AEDs, &lt,5% chance 3rd medication achieves control; Ketogenic diet: highly successful for Lennox-Gastaut, induces ketosis/mild acidosis; Cannabidiol (CBD): FDA-approved for Lennox-Gastaut and Dravet syndromes; Vagus nerve stimulation (VNS): 33-40% achieve ≥50% seizure reduction, &lt,3% seizure-free; VNS side effects: neck tingling, hoarseness, cough, dyspnea, 1% vocal cord paralysis/transient facial weakness, 1-2% infection risk